Good stress, bad stress - The delicate balance in the vasculature;Guter stress, schlechter stress - Die feine balance in blutgefäß en

Deutsches Arzteblatt

Volumn 106, Issue 42, 2009, Pages 677-684

  Wingler, Kirstin ^a   Schmidt, Harald H H W ^a  

^a MONASH UNIVERSITY   (Australia)

Author keywords

Antioxidants; Nitric oxide; Oxidative stress; Radicals; Vascular diagnostics

Indexed keywords

ANTIOXIDANT; CARDIOVASCULAR AGENT; RADICAL; SCAVENGER;

ANTIOXIDANT ACTIVITY; BLOOD VESSEL INJURY; CARDIOVASCULAR DISEASE; CELL METABOLISM; CLINICAL TRIAL; HUMAN; OXIDATIVE STRESS; REVIEW;

CARDIOTONIC AGENTS; FREE RADICALS; HUMANS; MODELS, CARDIOVASCULAR; MODELS, IMMUNOLOGICAL; OXIDATIVE STRESS; VASCULAR DISEASES;

EID: 72149134478     PISSN: 00121207     EISSN: None     Source Type: Journal    
DOI: 10.3238/arztebl.2009.0677     Document Type: Review

References (25)

1. Beckman JS: Understanding peroxynitrite biochemistry and its potential for treating human diseases. Archives of Biochemistry and Biophysics 2009; 484: 114-116
2. Vanhoutte PM: How we learned to say NO. Arterioscler Thromb Vasc Biol 2009; 29: 1156-1160
3. Bedard K, Krause KH: The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology. Physiol Rev 2007; 87: 245-313. (Pubitemid 46209993)
4. Schulz E, Jansen T, Wenzel P, Daiber A, Munzel T: Nitric oxide, tetrahydrobiopterin, oxidative stress, and endothelial dysfunction in hypertension. Antioxid Redox Signal 2008; 10: 1115-1126
5. Cobb JP: Nitric oxide synthase inhibition as therapy for sepsis: a decade of promise. Surg Infect 2001; 2: 93-100; discussion -1.
6. Pou S, Pou WS, Bredt DS, Snyder SH, Rosen GM: Generation of superoxide by purified brain nitric oxide synthase. J Biol Chem 1992; 267: 24173-24176
7. Böger GI, Rudolph TK, Maas R, Schwedhelm E, Dumbadze E, Bierend A, et al.: Asymmetric dimethylarginine determines the improvement of endothelium-dependent vasodilation by simvastatin effect of combination with oral L-arginine. J Am Coll Cardiol 2007; 49: 2274-2282 (Pubitemid 46856823)
8. Dotan Y, Pinchuk I, Lichtenberg D, Leshno M: Decision analysis supports the paradigm that indiscriminate supplementation of vitamin E does more harm than good. Arterioscler Thromb Vasc Biol 2009; 29: 1304-1309
9. Gallicchio L, Boyd K, Matanoski G, Tao XG, Chen L, Lam TK, et al.: Carotenoids and the risk of developing lung cancer: a systematic review. Am J Clin Nutr 2008; 88: 372-383
10. Ristow M, Zarse K, Oberbach A, Kloting N, Birringer M, Kiehntopf M, et al.: Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci USA 2009; 106: 8665-8670
11. Schafer ZT, Grassian AR, Song L, Jiang Z, Gerhart-Hines Z, Irie HY, et al.: Antioxidant and oncogene rescue of metabolic defects caus - ed by loss of matrix attachment. Nature 2009; 461: 109-113
12. Fichtlscherer S, Dimmeler S, Breuer S, Busse R, Zeiher AM, Fleming I: Inhibition of cytochrome P450 2C9 improves endothelium-dependent, nitric oxide-mediated vasodilatation in patients with coronary artery disease. Circulation 2004; 109: 178-183 (Pubitemid 38114136)
13. Lambeth JD: NOX enzymes, ROS, and chronic disease: an example of antagonistic pleiotropy. Free Radic Biol Med 2007; 43: 332-347
14. Guzik TJ, Chen W, Gongora MC, Guzik B, Lob HE, Mangalat D, et al.: Calcium-dependent NOX5 Nicotinamide Adenine Dinucleotide Phosphate Oxidase contributes to vascular oxidative stress in human coronary artery disease. Journal of the American College of Cardiology 2008; 52: 1803-1809
15. Bai Y, Sun L, Yang T, Sun K, Chen J, Hui R: Increase in fasting vascular endothelial function after short-term oral L-arginine is effective when baseline flow-mediated dilation is low: a metaanalysis of randomized controlled trials. Am J Clin Nutr 2009; 89: 77-84.
16. Schulman SP, Becker LC, Kass DA, Champion HC, Terrin ML, Forman S, et al.: L-arginine therapy in acute myocardial infarction: the Vascular Interaction With Age in Myocardial Infarction (VINTAGE MI) randomized clinical trial. JAMA 2006; 295: 58-64. (Pubitemid 43042690)
17. Maier W, Cosentino F, Lutolf RB, Fleisch M, Seiler C, Hess OM, et al.: Tetrahydrobiopterin improves endothelial function in patients with coronary artery disease. J Cardiovasc Pharmacol 2000; 35: 173-178 (Pubitemid 30073806)
18. Frantz S, Adamek A, Fraccarollo D, Tillmanns J, Widder JD, Dienesch C, et al.: The eNOS enhancer AVE 9488: a novel cardioprotectant against ischemia reperfusion injury. Basic Res Cardiol 2009: Jun 23 (Epub ahead of print). DOI: 10.1007/s00395-009-0041-3.
19. Evgenov OV, Pacher P, Schmidt PM, Hasko G, Schmidt HH, Stasch JP: NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential. Nat Rev Drug Discov 2006; 5: 755-768 (Pubitemid 44323702)
20. Munzel T, Wenzel P, Daiber A: Do we still need organic nitrates? J Am Coll Cardiol 2007; 49: 1296-1298
21. Mittendorf J, Weigand S, Alonso-Alija C, Bischoff E, Feurer A, Gerisch M, et al.: Discovery of riociguat (BAY 63-2521): a potent, oral stimulator of soluble guanylate cyclase for the treatment of pulmonary hypertension. ChemMedChem 2009; 4: 853-865
22. Stasch JP, Schmidt PM, Nedvetsky PI, Nedvetskaya TY, H SA, Meurer S, et al.: Targeting the heme-oxidized nitric oxide receptor for selective vasodilatation of diseased blood vessels. J Clin Invest 2006; 116: 2552-2561 (Pubitemid 44330154)
23. Lapp H, Mitrovic V, Franz N, Heuer H, Buerke M, Wolfertz J, et al.: Cinaciguat (BAY 58-2667) improves cardiopulmonary hemodynam ics in patients with acute decompensated heart failure. Circulation 2009; 119: 2781-2788
24. Vecchione C, Brandes RP: Withdrawal of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors elicits oxidative stress and induces endothelial dysfunction in mice. Circ Res 2002; 91: 173-179 (Pubitemid 34827229)
25. Jackson G: Torcetrapib: when global risk reduction goes 'off target'. Int J Clin Pract 2008; 62: 173-174